H epatitis C virus (HCV) infection is an import t tant public health problem worldwide. 1 As of June 1999, the World Health Organization (WHO) estimated that 169.7 million persons (3% of the world' s population) were chronically infected with HCV globally and that 3 to 4 million persons are newly infected each year. 2 The prevalence rate was estimated to be 5.3% in Africa (31.9 million cases), 4.6% in the Eastern Mediterranean region (21.3 million cases), 3 .9% in the West Pacific region (62.2 million cases), 2.15% in Southeast Asia (32.3 million cases), 1.7% in the Americas (13.1 million cases), and 1.03% in Europe (8.9 million cases). 1 Data on the prevalence of HCV int t fection in Saudi Arabia is limited. The objective of this study was to describe the number of HCV infections reported in Saudi Arabia during 11 years of surveillance from January 1995 through December 2005.
Methods
Saudi Arabia occupies most of the Arabian Peninsula with an area of about 2 240 000 sq km. It comprises 13 administrative provinces, namely, Makkah province (which includes the holy city of Makkah, Jeddah and Tayef ), Madinah province (which includes the holy city of Madinah), Riyadh province (which includes the capit t tal city, Riyadh), the Eastern province (which includes Dammam, Ahsa, and Hafr Albaten), Asir province (which includes Abha and Bisha), Jouf province (which includes Jouf and Qerayyat), Hudud Shamaliyah (North Borders) province (which includes Arar), and Baha, Jizan, Najran, Hail, Qassim, and Tabook provinct t es. 
Results
From January 1995 through December 2005, 24 948 cases with HCV infection were reported to the Ministry of Health, of whom 19 185 (76.9%) cases were Saudis. The number of cases by regions is shown in Table 1 . The number of HCV infections by region ranged from 33 to 9186 cases with a mean of 1247 cases per region. Figure 1 shows the number of HCV cases by year. Figure 2 shows the number of cases by age groups. The mean size of the pediatric (children <15 years of age) and adult (subjects ≥15 years of age) population during the study period was 8 186 369 and 11 878 260 indit t viduals, respectively. The total number of HCV cases reported among children was 998 cases and that among adults was 23 950 cases.
discussion
In 1989, HCV was first identified and found to be ret t sponsible for most transfusiontassociated nontA nontB viral hepatitis. 3, 4 Before HCV identification, the major causes of HCV infection worldwide were the use of unt t screened blood transfusions, and retuse of needles and syringes that were not adequately sterilized. Screening of blood and organ donors for HCV since 1990 has virt t tually eliminated the spread of HCV by these routes. Consequently, sharing contaminated needles has bet t come the most common mode of transmission of this infection. 1 Sexual and perinatal transmission may also occur, although less frequently.
5t7 Infection via other modes of transmission such as ear and body piercing, circumcision, tattooing, and cupping (Hijama) can oct t cur if inadequately sterilized equipment is used. 2 The prevalence of antitHCV in some neighbort t ing and other Islamic countries was reported as folt t lows: Algeria, 0.2%, Egypt, 18.1%, Indonesia, 2.1%, Iraq, 0.5%, Jordan, 2.1%, Kuwait, 3.3%, Libya, 7.9%, Malaysia, 3.0%, Mauritania, 1.1%, Morocco, 1.1%, Oman, 0.9%, Pakistan, 2.4%, Qatar, 2.8%, Somalia, 0.9%, Sudan, 3.2%, Tunisia, 0.7%, Turkey, 1.5%, United Arab Emirates, 0.8%, Palestine, 2.2%, and Yemen, 2.6%. 1 The prevalence of HCV in Saudi Arabia and the aforementioned countries is similar to the prevalence reported in industrialized countries. 1 One notable ext t ception is Egypt, in which the prevalence is known to be exceptionally high (up to 40% in some parts of Egypt), probably because of the use of nontdisposable, nont sterilized syringes to administer tartar emetic in mass treatment campaigns to control schistosomiasis in the 1960s through 1980s. Previous studies in Saudi Arabia indicated that the antitHCV prevalence was 0.4% to 1.7% for adults and 0.1% for children.
13t16 For instance, a study in Jeddah among 528 blood donors showed an antitHCV prevat t lence of 1.7%. 13 In a large study among 557 813 Saudi subjects of all ages in Riyadh province, the antitHCV prevalence was 1.1% for adults and 0.1% for children. 16 In the current study, the number of HCV infections reported in different regions of Saudi Arabia ranged from 33 to 9186 infections with a mean of 1247 infections per region. When expressed per population, these figures translate to a range of 0.016% to 0.322% and a mean of 0.124%. The number of int t fections reported among adults was 23 950 infections (0.202%) and that among children was 998 infections (0.012%). These figures do not necessarily reflect the actual prevalence of HCV because of the nature of the study design. The relatively low number of reported cases in this study was most likely due to underreportt t ing. The number of cases slightly and steadily rose from 1998 to 2002 perhaps owing to improved reporting and/or population growth estimated to be 3.3% ant t nually. From 2003 to 2005, the number of annually ret t ported cases seemed to have plateaued ( Figure 1) .
In this study, the number of HCV infections reportt t ed among children (0.012%) was much lower than that among adults (0.202%). This suggests that perinatal and childhood transmission is not a major mode of infection. On the other hand, the predominance of this infection in adults suggests that the other modes of transmission such as unscreened blood transfusion before 1990 and intravenous drug use are the main modes of infection in Saudi Arabia. Substance abuse is an increasing probt t lem in Saudi Arabia as it is in the rest of the world. The number of drug abusers annually admitted to det t toxification centers in Riyadh, Jeddah, Dammam, and Qassim from 1996 through 2001 ranged from 4740 to 6650 patients with an average annual increment of 5.1% (unpublished data). The prevalence of hepatitis C virus infection among 799 drug abusers from a volt t untary detoxification unit in Jeddah was reported to be 69%. 18 Thus, substance abuse seems to be a potential major risk factor for the spread of HCV among adults in Saudi Arabia.
The prevalence of HCV infection is lower than the prevalence of hepatitis B virus (HBV) in Saudi Arabia. A recent study showed that the prevalence of HBV infection in Saudi Arabia was on average 0.15% with wide variations between various regions ranging from 0.03% to 0.72%. 22 In that study, the prevalence of HBV among children was 0.05% and that among adults was 0.22%.
Since there is as yet no vaccine to prevent HCV int t fection, the strategy to prevent this infection in Saudi Arabia focuses mainly on health education, routine screening of blood and organ donors and hightrisk subt t jects such as household and sexual contacts of HCV patients, hemodialysis patients, patients requiring ret t current blood transfusion, intravenous drug users, and patients with other sexually transmitted infections. Additionally, implementation and maintenance of proper infection control practice in health care settings, including standard precautions and proper sterilization of surgical and dental equipment, and good hygienic practice in barbershops and traditional therapy settings such as wet cupping (Hijama) are emphasized in Saudi Arabia.
This study has several limitations. The fact that the study was not a crosstsectional survey but rather a passive reporting of antitHCV positive cases to the Ministry of Health obviously carried a risk of undert or perhaps overtestimation of the actual magnitude of HCV infection in Saudi Arabia. On the one hand, routine testing of lowtrisk groups (such as blood or organ donors and expatriates pretemployment) may underestimate the prevalence. On the other hand, testt t ing hightrisk groups (such as drug abusers, prisoners, contacts of HCVtinfected patients, patients with other sexually transmitted infections) may overestimate the actual prevalence. Another limitation is that informat t tion (liver function, cirrhosis, hepatocellular carcinoma) was not reported to the Ministry of Health as this was not part of the notification information mandated by the Ministry of Health. Further, different screening and confirmatory assays were used by different health sectors (the Ministry of Health, the Universities, the National Guard, the Armed Forces, King Faisal Specialist, and the private hospitals).
In conclusion, the incidence of HCV infection in Saudi Arabia is low. In the absence of an HCV vaccine, efforts to prevent the spread of this infection should fot t cus on ensuring safe blood, blood products, and organs for transplantation, ensuring safe use of syringes, neet t dles, sharps, and other equipment used for medical or traditional percutaneous interventions, implementation and maintenance of proper infection control practice in health care settings, and health education particularly targeting high risk groups.
